What are Special Types of Drug Delivery Vehicles?
Drug delivery system is a technology that delivers drugs into the body in a specific way to improve drug efficacy, reduce side effects or improve patient compliance. Formulation process development is a service to develop more special types of drug delivery carriers. Among them, microemulsions and oral soluble films are relatively popular new drug delivery systems, while mRNA-LNP is a more popular and proven hot delivery direction.
Formulation Process Development Applications
- Pediatric drug delivery vehicles
- Emergency drug development and delivery
- For preparation of capsule dosage forms
- Precisely deliver drugs to specific tissues or cells to improve treatment effectiveness and reduce side effects
- Mask the taste of drugs and improve patient acceptance
Why Choose Our Formulation Process Development Services?
Automatic Oral Thin Film Packaging
Large Scale Homogenizer
As a trusted drug delivery manufacturer in the industry, CD Bioparticles provides customized solutions with years of professional experience in oral membrane, microemulsion and mRNA-LNP vaccine research and development. We can bring the following advantages to your research and development process:
- Capable of containing a large number of medications
- Can interact more easily with biological fluids in the body, which helps improve drug absorption and distribution in the body.
- Improve drug stability
- Customize the release solution by adjusting its components to achieve sustained or controlled release.
- It can be administered by oral administration, topical application, injection, etc., making it suitable for different types of treatment needs. Some of these carriers dissolve quickly in the mouth, making them easy to take and absorb.
- Improve the solubility of hydrophobic drugs in water
- Improve patient compliance
- Some carrier systems can reduce the odor of drugs after being loaded with drugs, making them easier for patients to accept.
- Suitable for special groups
Popular Formulation Process Development Services
Drug delivery system is a technology that delivers drugs into the body in a specific way to improve drug efficacy, reduce side effects or improve patient compliance. Formulation process development is a service to develop more special types of drug delivery carriers. Among them, microemulsions and oral soluble films are relatively popular new drug delivery systems, while mRNA-LNP is a more popular and proven hot delivery direction.
Oral Soluble Film
Oral soluble film is a new type of drug dosage form. It is made by mixing drugs with polymer materials to form a film-like preparation. Its characteristics include being as thin as a stamp, dissolving quickly in the mouth without water or chewing, releasing drugs and being absorbed. It has the characteristics of rapid onset, high patient compliance, flexible dosage, taste masking and stability.
Microemulsion
A transparent or translucent dispersion system emerges spontaneously when oil and water combine with surfactants and co-surfactants. The microemulsion particles measure between 10 to 100 nanometers and categorize into oil-in-water (O/W), water-in-oil (W/O) and bicontinuous forms. The microemulsion maintains thermodynamic stability because it forms with ultra-low interfacial tension below 0.01 mN/m without needing mechanical emulsification. Hydrophobic drugs loaded into microemulsions experience significant solubility improvements.Secondly, it also performs well in changing the lipid arrangement of the stratum corneum and promoting drug penetration. Most importantly, microemulsions can be made into microemulsion gels to give them drug sustained-release properties, while protecting the drug and prolonging the drug's action time.
mRNA-LNP
The use of lipid nanoparticles for delivering nucleic acid vaccines presents an innovative approach called mRNA-LNP. The core component of RNA-LNP vaccines is lipid nanoparticles, which are mainly composed of four key components: cationic lipids, polyethylene glycol (PEG) lipids, cholesterol and phospholipids. Through electrostatic interaction and ion pairing four components establish a stable lipid bilayer structure which encapsulates mRNA to protect it from nuclease degradation and immune system clearance thus completing the immunization process.
5-Step Custom Formulation Process Development Process
Case Study
CD Bioparticles has greatly improved the solubility of olanzapine (OL) through Oral Soluble Film. Comparison of the dissolution curves of pure olanzapine (OL) and optimized fast-dissolving film (OFDF) confirms that Oral Soluble Film is significantly effective.
1. How does CD Bioparticles leverage Oral Soluble Films (OSFs) to enhance drug delivery?
Tailored Formulation: CD Bioparticles creates OSFs using customizable polymer matrices that dissolve quickly in the mouth for fast drug release and absorption as demonstrated by the optimized dissolution curves in the olanzapine case study.
Patient-Centric Solutions: The product targets pediatric and geriatric patients along with those experiencing dysphagia by removing bitter flavors and obviating the requirement for water and swallowing.
Scalability: The production process enables a smooth shift from small-batch prototypes to GMP-compliant mass production while maintaining batch-to-batch product quality.
2. What makes CD Bioparticles a leader in Microemulsion development?
Hydrophobic Drug Expertise: Our specialization includes creating oil-in-water (O/W) or bicontinuous microemulsions that enable the solubilization of poorly water-soluble medications like antipsychotics and antifungals.
Enhanced Permeation: The method enhances transdermal and mucosal delivery by optimizing surfactant/co-surfactant ratios to break down skin/tissue barriers.
Stability & Versatility: Our develop thermodynamically stable microemulsion gels that deliver drugs over extended periods and validates their performance through rigorous stability testing.3. How does CD Bioparticles advance mRNA-LNP vaccine development?
Proprietary Lipid Libraries: CD Bioparticles provides cationic lipids, PEGylated lipids, and phospholipids to enhance mRNA encapsulation efficiency and enable precise delivery targeting.
End-to-End Support: Ensures high immunogenicity and low toxicity throughout the process from lipid nanoparticle (LNP) design to in vivo validation.
Rapid Scalability: Production facilities meeting GMP standards enable both clinical trials and mass manufacturing which support timely vaccine development during pandemics.
4. Why prioritize CD Bioparticles for specialized drug delivery services?
Competitive Edge:
Technical Mastery: Our team possesses extensive knowledge in specialized systems including OSFs, microemulsions, and mRNA-LNP developed through more than a decade of industry research and development.
Regulatory Compliance: Following FDA/EMA guidelines during formulation development leads to more efficient regulatory approvals.
End-to-End Customization: Solutions for diverse needs:
Pediatrics: Taste-masked OSFs for pediatric drugs.
Emergency Use: Accelerated creation processes for mRNA-LNP vaccines address new pathogenic threats.
Targeted Delivery: Tissue-specific LNPs or microemulsions for oncology/neurology.
Unmatched Support: In-depth technical documentation with stability studies and scalability assurances.